Skip to main content

QuantumBio Receives SBIR Grant for In Silico Screening Against Bioterrorism

NEW YORK, July 7 (GenomeWeb News) - QuantumBio has been awarded a Phase I Small Business Innovation Research grant for $63,353 from the US Army Research Office to apply its in silico drug-discovery tools to the study of "next-generation tools to counter bioterrorism," the company said today.

 

QuantumBio said that the project, entitled "In Silico Screening for Biothreat Countermeasures," will be conducted in collaboration with a number of undisclosed industry partners.

 

The partners will work together to further validate the use of QMScore, QuantumBio's proprietary scoring algorithm, for developing counter-bioterrorism tools, QuantumBio said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.